WO2005065047A3 - Stable oral composition containing desloratadine - Google Patents

Stable oral composition containing desloratadine Download PDF

Info

Publication number
WO2005065047A3
WO2005065047A3 PCT/IN2004/000399 IN2004000399W WO2005065047A3 WO 2005065047 A3 WO2005065047 A3 WO 2005065047A3 IN 2004000399 W IN2004000399 W IN 2004000399W WO 2005065047 A3 WO2005065047 A3 WO 2005065047A3
Authority
WO
WIPO (PCT)
Prior art keywords
oral composition
stable oral
composition containing
desloratadine
containing desloratadine
Prior art date
Application number
PCT/IN2004/000399
Other languages
French (fr)
Other versions
WO2005065047A2 (en
Inventor
Pankaj Khapra
Nitin Bhalachand Dharmadhikari
Original Assignee
Sun Pharmaceutical Ind Ltd
Pankaj Khapra
Nitin Bhalachand Dharmadhikari
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Ind Ltd, Pankaj Khapra, Nitin Bhalachand Dharmadhikari filed Critical Sun Pharmaceutical Ind Ltd
Priority to US10/583,842 priority Critical patent/US7955620B2/en
Priority to EP04820978A priority patent/EP1696881A2/en
Publication of WO2005065047A2 publication Critical patent/WO2005065047A2/en
Publication of WO2005065047A3 publication Critical patent/WO2005065047A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine

Abstract

The present invention provides a stable oral composition comprising a therapeutically effective amount of desloratadine and a stabilizer selected from the group comprising an antioxidant, a pharmaceutically acceptable organic compound that provides an alkaline pH, an alkali metal salt, or mixtures thereof, and pharmaceutically acceptable excipients.
PCT/IN2004/000399 2003-12-23 2004-12-23 Stable oral composition containing desloratadine WO2005065047A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US10/583,842 US7955620B2 (en) 2003-12-23 2004-12-23 Stable oral composition
EP04820978A EP1696881A2 (en) 2003-12-23 2004-12-23 Stable oral composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1304MU2003 2003-12-23
IN1304/MUM/2003 2003-12-23

Publications (2)

Publication Number Publication Date
WO2005065047A2 WO2005065047A2 (en) 2005-07-21
WO2005065047A3 true WO2005065047A3 (en) 2006-04-27

Family

ID=34746670

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2004/000399 WO2005065047A2 (en) 2003-12-23 2004-12-23 Stable oral composition containing desloratadine

Country Status (3)

Country Link
US (1) US7955620B2 (en)
EP (1) EP1696881A2 (en)
WO (1) WO2005065047A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK287105B6 (en) * 1999-12-20 2009-12-07 Schering Corporation Bilayer sustained release oral dosage composition
WO2006008512A2 (en) * 2004-07-16 2006-01-26 Cipla Limited Anti-histaminic composition
CA2547274A1 (en) * 2005-05-20 2006-11-20 Dr. Reddy's Laboratories Limited Stable desloratadine compositions
US20070004671A1 (en) * 2005-05-20 2007-01-04 Agarwal Sudeep K Stable desloratadine compositions
WO2007096733A2 (en) * 2006-02-22 2007-08-30 Orchid Chemicals & Pharmaceuticals Limited Desloratadine-containing formulation stabilized with cyclodextrin
TR200806298A2 (en) 2008-08-22 2010-03-22 Bi̇lgi̇ç Mahmut Pharmaceutical formulation
EP2379056B1 (en) * 2008-11-28 2016-04-13 KRKA, d.d., Novo mesto Solid pharmaceutical composition comprising at least one stabilizing agent
TR201007652A2 (en) * 2010-09-20 2012-04-24 Bi̇lgi̇ç Mahmut Synergistic effect.
WO2013034173A1 (en) * 2011-09-06 2013-03-14 Synthon Bv Pramipexole extended release tablets
RU2550958C2 (en) * 2013-04-23 2015-05-20 Общество с ограниченной ответственностью "Трейдсервис" Dosage form containing desloratadine and method for producing it
CN111419820B (en) * 2020-04-23 2022-03-25 合肥医工医药股份有限公司 Desloratadine citrate disodium capsule and preparation method and application thereof
EP4230211A1 (en) 2020-12-04 2023-08-23 Laboratorios Silanes, S.A. de C.V. Pharmaceutical combination of a corticosteroid and an antihistamine for the treatment and control of the inflammatory component of allergic processes

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030031713A1 (en) * 1999-12-20 2003-02-13 Schering Corporation Extended release oral dosage composition
CN1415613A (en) * 2002-11-19 2003-05-07 沈阳华泰药物研究所 Stable composition of medicaments of desloratadine salt or medicament containing salt utilized to cure allergic disease
US20030118654A1 (en) * 2001-12-07 2003-06-26 B. Santos Joyce Bedelia Taste masked aqueous liquid pharmaceutical composition
US20030194430A1 (en) * 2002-04-10 2003-10-16 Miller Frederick H. Process for encapsulating multi-phase, multi-compartment capsules for therapeutic compositions
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
WO2004080461A2 (en) * 2003-03-12 2004-09-23 TEVA Gyógyszergyár Részvénytársaság Stable pharmaceutical compositions of desloratadine
CN1552324A (en) * 2003-05-28 2004-12-08 天津药物研究院 Medicinal composition for stabilizing delotadine in preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW522014B (en) 1997-02-07 2003-03-01 Sepracor Inc Lactose-free, non-hygroscopic and anhydrous pharmaceutical unit dosage form containing descarboethoxyloratadine
US6100274A (en) 1999-07-07 2000-08-08 Schering Corporation 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions
UA80393C2 (en) * 2000-12-07 2007-09-25 Алтана Фарма Аг Pharmaceutical preparation comprising an pde inhibitor dispersed on a matrix
US6605302B2 (en) * 2001-07-17 2003-08-12 Osmotica Corp. Drug delivery device containing oseltamivir and an H1 antagonist

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US20030031713A1 (en) * 1999-12-20 2003-02-13 Schering Corporation Extended release oral dosage composition
US20030118654A1 (en) * 2001-12-07 2003-06-26 B. Santos Joyce Bedelia Taste masked aqueous liquid pharmaceutical composition
US20030194430A1 (en) * 2002-04-10 2003-10-16 Miller Frederick H. Process for encapsulating multi-phase, multi-compartment capsules for therapeutic compositions
CN1415613A (en) * 2002-11-19 2003-05-07 沈阳华泰药物研究所 Stable composition of medicaments of desloratadine salt or medicament containing salt utilized to cure allergic disease
WO2004080461A2 (en) * 2003-03-12 2004-09-23 TEVA Gyógyszergyár Részvénytársaság Stable pharmaceutical compositions of desloratadine
CN1552324A (en) * 2003-05-28 2004-12-08 天津药物研究院 Medicinal composition for stabilizing delotadine in preparation

Also Published As

Publication number Publication date
WO2005065047A2 (en) 2005-07-21
US20070053974A1 (en) 2007-03-08
EP1696881A2 (en) 2006-09-06
US7955620B2 (en) 2011-06-07

Similar Documents

Publication Publication Date Title
MXPA03006357A (en) Pharmaceutical composition having reduced tendency for drug crystallization.
WO2003048081A3 (en) Glycinamides as factor xa inhibitors
IL162118A0 (en) Pharmaceutical compositions containing an orally active taxane derivative
TWI328576B (en) Diketohydrazine derivative compound, medicament containing same as active ingredient
EP1650192A4 (en) Quinolone derivative or salt thereof
AU2003255845A1 (en) Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents
IL161857A0 (en) Pharmaceutical compositions of 5,7,14-triazatetracycloÄ10.3.1.0(2,11).0(4,9)Ü-hexadeca-2(11)3,5,7,9-pentaene
WO2004004657A3 (en) Hiv integrase inhibitors
RS36904A (en) Polymorphous form or rimonabant,preparation method and pharmaceutical, compositions containing same
WO2007022956A3 (en) Pharmaceutical compositions comprising a ph-dependent drug, a ph modifier and a retarding agent
HK1048271A1 (en) Pharmaceutical composition for inhibiting retinoidskin damage.
WO2005117895A8 (en) Compositions comprising meloxicam
WO2003057650A3 (en) Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate
WO2006072070A3 (en) Pharmaceutical formulations of gallium salts
WO2005065047A3 (en) Stable oral composition containing desloratadine
WO2002053519A3 (en) Hydrophobic polyamine analogs and methods for their use
AP1766A (en) Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation.
ZA200305803B (en) Prevention of diabetes by administration of GnRH antagonists.
ZA200501387B (en) Antimicrobial compositions.
WO2004098594A3 (en) Dosage form containing pantoprazole as active ingredient
WO2003066022A3 (en) Stable pharmaceutical composition useful for treating gastrointestinal disorders
WO2004098577A3 (en) Dosage form containing (s)-pantoprazole as active ingredient
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents
ZA200403323B (en) Anthelmintic composition.
TW200519126A (en) An antibacterial agent a against propionibacterium acnes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2007053974

Country of ref document: US

Ref document number: 10583842

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

WWE Wipo information: entry into national phase

Ref document number: 2004820978

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2004820978

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 10583842

Country of ref document: US